1. Home
  2. IVT vs NVAX Comparison

IVT vs NVAX Comparison

Compare IVT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InvenTrust Properties Corp.

IVT

InvenTrust Properties Corp.

N/A

Current Price

$31.58

Market Cap

2.3B

Sector

Real Estate

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$10.67

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVT
NVAX
Founded
2005
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
IVT
NVAX
Price
$31.58
$10.67
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
★ $35.00
$14.44
AVG Volume (30 Days)
635.3K
★ 6.8M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 3.16%
N/A
EPS Growth
★ 647.37
309.76
EPS
★ 0.33
N/A
Revenue
$299,169,000.00
★ $1,123,479,000.00
Revenue This Year
$12.43
N/A
Revenue Next Year
$6.69
N/A
P/E Ratio
$96.55
★ N/A
Revenue Growth
9.20
★ 64.69
52 Week Low
$27.06
$6.20
52 Week High
$37.22
$13.39

Technical Indicators

Market Signals
Indicator
IVT
NVAX
Relative Strength Index (RSI) 60.10 52.16
Support Level $30.42 $7.93
Resistance Level $31.71 $11.73
Average True Range (ATR) 0.69 0.79
MACD 0.24 -0.05
Stochastic Oscillator 75.96 70.99

Price Performance

Historical Comparison
IVT
NVAX

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: